Danaher Corporation vs Under Armour Inc Class A — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while Under Armour Inc Class A trades at $4.93 (market cap $2.07B). The key difference: Danaher Corporation is far larger — about 73.9× Under Armour Inc Class A's market cap, and Danaher Corporation pays a 0.74% dividend while Under Armour Inc Class A pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Under Armour Inc Class A for 99 Days on average.
| DHR | UAA | |
|---|---|---|
Market Cap | $152.87B | $2.07B |
Volume | 5,228,698 | 12,050,442 |
Sector | Health | Consumer Cyclical |
52-Week High | $242.05 | $8.14 |
52-Week Low | $161.91 | $4.17 |
Typical Hold Time | 69 Days | 99 Days |
Enterprise Value | $175.08B | $3.05B |
Dividend Yield | 0.74% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
Under Armour (UAA) trades at $4.88, up 1.24% with a mixed technical picture showing bullish moving averages but neutral oscillators. The company faces fundamental challenges with negative net income margins (-9.99%) and declining revenue trends, though valuation metrics like P/S (0.42) appear attractive. Recent news highlights brand transformation efforts amid softer demand, with the company maintaining profitability outlook despite revenue cuts.
The outlook remains cautious with significant execution risks as Under Armour navigates weak consumer spending. Analyst consensus shows modest upside to the $5.79 price target, but persistent revenue declines and negative cash flow trends pose substantial headwinds for shareholder value recovery in the near term.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.
Read more on UAA →